Applied Materials vs. ASML: Which Technology Stock Is a Better Buy in 2026?

ASML is presented as the preferred long-term semiconductor-equipment investment, supported by its monopoly in EUV lithography and more than 20% year-over-year revenue growth in its most recent quarter alongside a substantial full-year outlook increase. In FY2025, ASML generated approximately $37.1B of revenue (+15.6%), $10.9B of net income, a 29.4% margin, and $12.1B of free cash flow, exceeding Applied Materials' $28.4B revenue (+4.4%), $7.0B net income, and $5.7B free cash flow. Applied Materials trades at lower valuation multiples—36.1x forward P/E and 11.9x sales versus ASML's 39.2x and 16.4x—but faces greater competitive, customer-concentration, and export-control risks, including a $252M February 2026 settlement.

Analysis

The relevant distinction is not simply monopoly versus competition, but where incremental AI capex lands in the process flow. ASML captures the leading-edge lithography bottleneck, yet its earnings are unusually exposed to customer tool-acceptance timing and a small number of fabs; high-NA adoption can create order volatility before it creates durable revenue. TSM’s and Intel’s leading-node ramp schedules, rather than aggregate AI-chip demand, are the near-term determinants of ASML’s upside.

AMAT is more levered to wafer-fab-equipment intensity: advanced packaging, gate-all-around transistors, backside power delivery, and DRAM layer counts require additional deposition, etch, and inspection steps even when lithography spend pauses. This makes AMAT a potentially better 6-18 month beneficiary if AI demand broadens from leading-edge GPU logic into HBM and mature-node power/connectivity chips. The offset is that export-control compliance risk can translate into lost service revenue, customer qualification delays, and a structurally higher discount rate—not merely a one-time legal expense.

Consensus is likely too comfortable paying a premium for ASML’s scarcity while underweighting the risk that tool deliveries have been pulled forward by subsidized fab builds. A delayed high-NA production transition, weak Intel foundry execution, or tighter Dutch restrictions would matter more to ASML’s multiple than to its long-run moat. Conversely, evidence that TSM and Samsung are accelerating high-NA insertion would justify further ASML outperformance despite an already demanding valuation.

There is no broad sector-wide read-through from this item alone; the investable signal is relative. Monitor quarterly bookings, backlog conversion, China revenue mix, and customer capex guidance before treating favorable narrative momentum as an earnings-estimate catalyst.

Key Decisions for Investors

• Maintain a modest 3-6 month long ASML / short AMAT pair only on a 5-10% ASML pullback or after a verified order-book update; target 10-15% relative return. Stop if ASML cuts next-12-month revenue guidance or high-NA shipment/acceptance milestones slip by more than one quarter.
• For a 6-18 month diversification of the AI equipment thesis, add AMAT against a short KLAC rather than chasing ASML outright: AMAT has greater exposure to process-step intensity and packaging, while KLAC is more vulnerable if leading-edge wafer starts disappoint. Reassess if AMAT China mix rises materially or another export-control enforcement action emerges.
• Use TSM quarterly capex and leading-node utilization as the primary catalyst calendar: an upward capex revision supports both names, while a flat budget with stronger advanced-packaging spend favors AMAT relative to ASML.
• Avoid directional AMD exposure based on lithography demand; AMD is a fabless customer of TSM rather than a direct purchaser of ASML systems. The cleaner listed demand proxies are TSM and equipment suppliers, with TSM capacity plans serving as the confirmation signal.